Butyrophilin-like 2 gene is associated with ulcerative colitis in the Japanese under strong linkage disequilibrium with HLA-DRB1*1502

Tissue Antigens

Volumn 70, Issue 2, 2007, Pages 128-135

  Mochida, A ^a   Kinouchi, Y ^a   Negoro, K ^a   Takahashi, S ^a   Takagi, S ^a   Nomura, E ^a   Kakuta, Y ^a   Tosa, M ^a   Shimosegawa, T ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Butyrophilin like 2; Crohn's disease; Human leukocyte antigen; Inflammatory bowel disease; Polymorphism; Ulcerative colitis

Indexed keywords

HLA DR ANTIGEN; MESSENGER RNA;

ADULT; ARTICLE; BUTYROPHILIN LIKE 2 GENE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENTERITIS; FEMALE; GENE LINKAGE DISEQUILIBRIUM; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; MALE; MEMBRANE GLYCOPROTEINS;

EID: 34447094130     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2007.00866.x     Document Type: Article

References (55)

1. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001 : 411 : 603 6.
2. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001 : 411 : 599 603.
3. Stoll M, Corneliussen B, Costello CM et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 2004 : 36 : 476 80.
4. Peltekova VD, Wintle RF, Rubin LA et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004 : 36 : 471 5.
5. Yamazaki K, McGovern D, Ragoussis J et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 2005 : 14 : 3499 506.
6. Danze PM, Colombel JF, Jacquot S et al. Association of HLA class II genes with susceptibility to Crohn's disease. Gut 1996 : 39 : 69 72.
7. Trachtenberg EA, Yang H, Hayes E et al. HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populations. Hum Immunol 2000 : 61 : 326 33.
8. Yoshitake S, Kimura A, Okada M, Yao T, Sasazuki T. HLA class II alleles in Japanese patients with inflammatory bowel disease. Tissue Antigens 1999 : 53 : 350 8.
9. Matake H, Okabe N, Naito S, Yao T. An HLA study on 149 Japanese patients with Crohn's disease. Gastroenterol Jpn 1992 : 27 : 496 501.
10. Nakajima A, Matsuhashi N, Kodama T, Yazaki Y, Takazoe M, Kimura A. HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology 1995 : 109 : 1462 7.
11. Futami S, Aoyama N, Honsako Y et al. HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression. Dig Dis Sci 1995 : 40 : 814 8.
12. Sugimura K, Asakura H, Mizuki N et al. Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis. Hum Immunol 1993 : 36 : 112 8.
13. Shanahan F. Crohn's disease. Lancet 2002 : 359 : 62 9.
14. Miretti MM, Walsh EC, Ke X et al. A high-resolution linkage- disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet 2005 : 76 : 634 46.
15. Valentonyte R, Hampe J, Huse K et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005 : 37 : 357 64.
16. Traherne JA, Barcellos LF, Sawcer SJ et al. Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15. Hum Mol Genet 2006 : 15 : 155 61.
17. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997 : 336 : 1224 34.
18. Ziegenhagen MW, Muller-Quernheim J. The cytokine network in sarcoidosis and its clinical relevance. J Intern Med 2003 : 253 : 18 30.
19. Muller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 1998 : 12 : 716 38.
20. Podolsky DK. Inflammatory bowel disease (1). N Engl J Med 1991 : 325 : 928 37.
21. Kataria YP, Holter JF. Immunology of sarcoidosis. Clin Chest Med 1997 : 18 : 719 39.
22. Radford-Smith G, Jewell DP. Cytokines and inflammatory bowel disease. Baillieres Clin Gastroenterol 1996 : 10 : 151 64.
23. Nguyen T, Liu XK, Zhang Y, Dong C. BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation. J Immunol 2006 : 176 : 7354 60.
24. Fielding JF. The relative risk of inflammatory bowel disease among parents and siblings of Crohn's disease patients. J Clin Gastroenterol 1986 : 8 : 655 7.
25. Cavanaugh JA. IBD International Genetics Consortium: international cooperation making sense of complex disease. Inflamm Bowel Dis 2003 : 9 : 190 3.
26. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006 : 55 : 749 53.
27. Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1974 : 1 : 1067 70.
28. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005 : 21 : 263 5.
29. Hiroki M, Kinouchi Y, Takahashi S et al. DRB1*1502 does not affect disease extent or age at diagnosis or severity in patients with ulcerative colitis in Japan. Gastroenterology 2002 : 122 (Suppl A-301.
30. Bunce M, O'Neill CM, Barnardo MC et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995 : 46 : 355 67.
31. Ota M, Seki T, Fukushima H, Tsuji K, Inoko H. HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 1992 : 39 : 187 202.
32. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002 : 347 : 417 29.
33. Li Y, Wollnik B, Pabst S et al. BTNL2 gene variant and sarcoidosis. Thorax 2006 : 61 : 273 4.
34. Hampe J, Schreiber S, Shaw SH et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet 1999 : 64 : 808 16.
35. Rioux JD, Silverberg MS, Daly MJ et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000 : 66 : 1863 70.
36. Sugimura K, Ota M, Matsuzawa J et al. A close relationship of triplet repeat polymorphism in MHC class I chain-related gene A (MICA) to the disease susceptibility and behavior in ulcerative colitis. Tissue Antigens 2001 : 57 : 9 14.
37. Seki SS, Sugimura K, Ota M et al. Stratification analysis of MICA triplet repeat polymorphisms and HLA antigens associated with ulcerative colitis in Japanese. Tissue Antigens 2001 : 58 : 71 6.
38. Sugimura M, Kinouchi Y, Negoro K et al. Analysis of MICA alleles in Japanese patients with ulcerative colitis. Gastroenterology 2004 : 126 (Suppl 2 A-353.
39. Oomori S, Kinouchi Y. Association between polymorphisms in the inhibitor of kappa B-like protein (IKBL) gene and inflammatory bowel disease in Japan. J Gastroenterol Hepatol 2004 : 19 (Suppl A422.
40. Cullen M, Perfetto SP, Klitz W, Nelson G, Carrington M. High-resolution patterns of meiotic recombination across the human major histocompatibility complex. Am J Hum Genet 2002 : 71 : 759 76.
41. Walsh EC, Mather KA, Schaffner SF et al. An integrated haplotype map of the human major histocompatibility complex. Am J Hum Genet 2003 : 73 : 580 90.
42. Stenzel A, Lu T, Koch WA et al. Patterns of linkage disequilibrium in the MHC region on human chromosome 6p. Hum Genet 2004 : 114 : 377 85.
43. Dong RP, Kimura A, Numano F, Nishimura Y, Sasazuki T. HLA-linked susceptibility and resistance to Takayasu arteritis. Heart Vessels Suppl 1992 : 7 : 73 80.
44. Takeuchi F, Nakano K, Yamada H et al. Association of HLA-DR with progressive systemic sclerosis in Japanese. J Rheumatol 1994 : 21 : 857 63.
45. Yukioka M, Wakitani S, Murata N et al. Elderly-onset rheumatoid arthritis and its association with HLA-DRB1 alleles in Japanese. Br J Rheumatol 1998 : 37 : 98 101.
46. Tomono N, Mori M, Nakajima S et al. HLA-DRB1*15021 is the predominant allele in Japanese patients with juvenile dermatomyositis. J Rheumatol 2004 : 31 : 1847 50.
47. Shichishima T, Okamoto M, Ikeda K et al. HLA class II haplotype and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood 2002 : 100 : 22 8.
48. Kira J. Molecular immunogenetic approach to the pathogenesis of multiple sclerosis. Rinsho Shinkeigaku 2002 : 42 : 1198 200.
49. Matsumoto K, Yasugi T, Nakagawa S et al. Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer. Int J Cancer 2003 : 106 : 919 22.
50. Kojima Y, Takahara S, Nonomura N et al. HLA-DRB genotypes in Japanese patients with renal cell carcinoma. Oncology 2000 : 59 : 57 62.
51. Sato M, Ohashi J, Tsuchiya N et al. Association of HLA-A*3303- B*4403-DRB1*1302 haplotype, but not of TNFA promoter and NKp30 polymorphism, with postherpetic neuralgia (PHN) in the Japanese population. Genes Immun 2002 : 3 : 477 81.
52. Tsujimura A, Ota M, Katsuyama Y et al. Susceptibility gene for non-obstructive azoospermia located near HLA-DR and -DQ loci in the HLA class II region. Hum Genet 2002 : 110 : 192 7.
53. Azuma H, Sada M, Tsuji T, Ueda H, Katsuoka Y. Relationship between HLA-DR antigen and HLA-DRB1 alleles and prostate cancer in Japanese men. Int Urol Nephrol 1999 : 31 : 343 9.
54. Stammers M, Rowen L, Rhodes D, Trowsdale J, Beck S. BTL-II: a polymorphic locus with homology to the butyrophilin gene family, located at the border of the major histocompatibility complex class II and class III regions in human and mouse. Immunogenetics 2000 : 51 : 373 82.
55. Orozco G, Eerligh P, Sanchez E et al. Analysis of a functional BTNL2 polymorphism in type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus. Hum Immunol 2005 : 66 : 1235 41.